Wednesday, June 25, 2025 8:48:27 PM
Gary you were pretty close according to Gemini. In LA alone 300-500!
Predicting the exact number of Glioblastoma Multiforme (GBM) cases for a specific region like Los Angeles, California, for a future year (2026) is challenging, as these figures are typically reported retrospectively by cancer registries. However, we can make an informed estimate based on available incidence rates and population data.
Here's what we know:
* National Incidence: The national incidence rate of GBM in the United States is generally cited as 3.09 to 5.0 cases per 100,000 person-years. Some reports mention ranges from 3.19 to 4.17 per 100,000.
* LA County Specifics: A study looking at GBM in Los Angeles County from 1974-1999 found a "population-based description," indicating that local data exists, but a precise, up-to-date incidence rate for LA County for future years isn't readily available in the search results.
* Population of Los Angeles County: The population of Los Angeles County is substantial, typically ranging from 9.8 to 10 million people.
Estimation for LA County (2026):
Let's use a conservative national incidence rate of 3.5 cases per 100,000 people (within the reported range) and an approximate population of 10 million (10,000,000) for Los Angeles County.
Calculation:
(10,000,000 \text{ people} / 100,000 \text{ people}) \times 3.5 \text{ cases} = 100 \times 3.5 = 350 \text{ cases}
Therefore, based on national incidence rates and the population of Los Angeles County, it is estimated that approximately 300 to 500 new cases of GBM could be expected in Los Angeles County next year (2026).
Important Considerations:
* Estimates, not Exact Figures: This is an estimation. Actual numbers can vary due to many factors, including demographic shifts, improved diagnostic techniques, and environmental factors.
* Age and Gender: GBM incidence is higher in older age groups and generally higher in males than females.
* Socioeconomic Status: Some studies suggest a positive correlation between higher socioeconomic status and GBM incidence.
* Data Lag: Cancer statistics are often reported with a lag of several years as data is collected and analyzed.
Predicting the exact number of Glioblastoma Multiforme (GBM) cases for a specific region like Los Angeles, California, for a future year (2026) is challenging, as these figures are typically reported retrospectively by cancer registries. However, we can make an informed estimate based on available incidence rates and population data.
Here's what we know:
* National Incidence: The national incidence rate of GBM in the United States is generally cited as 3.09 to 5.0 cases per 100,000 person-years. Some reports mention ranges from 3.19 to 4.17 per 100,000.
* LA County Specifics: A study looking at GBM in Los Angeles County from 1974-1999 found a "population-based description," indicating that local data exists, but a precise, up-to-date incidence rate for LA County for future years isn't readily available in the search results.
* Population of Los Angeles County: The population of Los Angeles County is substantial, typically ranging from 9.8 to 10 million people.
Estimation for LA County (2026):
Let's use a conservative national incidence rate of 3.5 cases per 100,000 people (within the reported range) and an approximate population of 10 million (10,000,000) for Los Angeles County.
Calculation:
(10,000,000 \text{ people} / 100,000 \text{ people}) \times 3.5 \text{ cases} = 100 \times 3.5 = 350 \text{ cases}
Therefore, based on national incidence rates and the population of Los Angeles County, it is estimated that approximately 300 to 500 new cases of GBM could be expected in Los Angeles County next year (2026).
Important Considerations:
* Estimates, not Exact Figures: This is an estimation. Actual numbers can vary due to many factors, including demographic shifts, improved diagnostic techniques, and environmental factors.
* Age and Gender: GBM incidence is higher in older age groups and generally higher in males than females.
* Socioeconomic Status: Some studies suggest a positive correlation between higher socioeconomic status and GBM incidence.
* Data Lag: Cancer statistics are often reported with a lag of several years as data is collected and analyzed.
Bullish
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
